| NDC Code | 70860-605-03 |
|---|
| Package Description | 25 VIAL in 1 CARTON (70860-605-03) / 2 mL in 1 VIAL (70860-605-41) |
|---|
| Product NDC | 70860-605 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Dexmedetomidine |
|---|
| Non-Proprietary Name | Dexmedetomidine |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20180301 |
|---|
| End Marketing Date | 20240731 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA209065 |
|---|
| Manufacturer | Athenex Pharmaceutical Division, LLC. |
|---|
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
|---|
| Strength | 100 |
|---|
| Strength Unit | ug/mL |
|---|
| Pharmacy Classes | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
|---|